周五盘前，生殖健康福利管理公司Progyny（PGNY）股价大涨7.59%，主要受到该公司发布的强劲季度业绩报告的推动。
Progyny公布的截至6月30日的第二季度调整后每股收益为0.19美元，超过分析师平均预期的0.16美元。公司营收同比增长9.5%，达到3.3287亿美元，同样高于分析师预期的3.2008亿美元。此外，Progyny报告的季度净收入为1711万美元，显示出公司在当前市场环境下仍保持着稳健的盈利能力。
值得注意的是，华尔街分析师对Progyny保持乐观态度。目前，分析师对该公司股票的平均评级为"买入"，其中5个评级为"强烈买入"或"买入"，5个为"持有"，没有"卖出"或"强烈卖出"评级。分析师给出的12个月目标价中位数为28.00美元，较上次收盘价23.06美元高出约17.6%，反映出市场对Progyny未来增长前景的信心。在过去一个季度，Progyny的股价已上涨6.8%，今年迄今为止更是累计上涨了36.2%，显示出强劲的市场表现。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.